Glycogen synthase kinase 3 beta (GSK3beta) as a promising target to prevent beta-amyloide and tau toxicity in Alzheimer disease

Fauconneau, B; Noël, A.; Barrier, L; Prie, G.; Ingrand, S

doi:10.1016/j.toxlet.2010.03.749

Record: found
Abstract: not found
Article: not found

Glycogen synthase kinase 3 beta (GSK3beta) as a promising target to prevent beta-amyloide and tau toxicity in Alzheimer disease

Author(s): B. Fauconneau , A. Noel , L. Barrier , G. Prie , S. Ingrand

Publication date Created: July 2010

Publication date (Print): July 2010

Journal: Toxicology Letters

Publisher: Elsevier BV

Read this article at

ScienceOpenPublisher

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Toxicology Letters

Abbreviated Title: Toxicology Letters

Publisher: Elsevier BV

ISSN (Print): 03784274

Publication date Created: July 2010

Publication date (Print): July 2010

Volume: 196

Page: S223

Article

DOI: 10.1016/j.toxlet.2010.03.749

SO-VID: cfc123a0-9d97-414f-b289-e2d2fa9c7d64

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_

Glycogen synthase kinase 3 beta (GSK3beta) as a promising target to prevent beta-amyloide and tau toxicity in Alzheimer disease

Read this article at

Related collections

Alternative approaches to Alzheimer's Disease

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 1,340